Persistent Cardiovascular Effects of COVID-19 Viral Infection Trial (PERCEIVE)

Who May Qualify: 1. History of COVID-19 infection 2. Live within a geographically accessible area for follow-up Who Should NOT Join This Trial: 1. Valvular stenosis or regurgitation of \>moderate severity 2. History of previous heart failure (baseline New York Heart Association (NYHA) classification \>2) 3. Inability to acquire interpretable images (identified from baseline echo) 4. Contraindications to beta blockers or angiotensin-converting enzyme inhibitors 5. Oncologic (or other) life expectancy \<12 months or any other medical condition (including pregnancy) that results in the belief (deemed by the Chief Investigators) that it is not appropriate for the patient to participate in this trial 6. Already taking both angiotensin converting enzyme inhibitors/ angiotensin receptor blockers and beta blockers, or intolerance (or allergy) to both. 7. Mobility impairment that would impact participants' ability to perform exercise 8. Unable to provide written willing to sign a consent form to participate in this study Always talk to your doctor about whether this trial is right for you.